CETA Could Cost Drug Plans Billions

The Globe covers a new report that projects that the proposed Canada – European Union Trade Agreement could add nearly $3 billion in additional costs to provincial drug plans.

Tags: /

One Comment

  1. They proceed from a false assumption
    That drug research is 100% about the money.